×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
LivaNova Adds Ahmet Tezel as Chief Innovation Officer
Sleep Review
Ahmet Tezel will leverage over two decades of R&D experience to accelerate the development of medical technologies.
1 week ago
LivaNova PLC (NASDAQ:LIVN) Q1 2024 Earnings Call Transcript
Yahoo Finance
LivaNova PLC (NASDAQ:LIVN) Q1 2024 Earnings Call Transcript May 1, 2024 LivaNova PLC misses on earnings expectations.
1 week ago
LivaNova: Focus Is Paying Off (NASDAQ:LIVN)
Seeking Alpha
LivaNova's epilepsy products are scaling, with new implants driving growth and a strong recurring revenue base. See why LIVN stock is a Buy.
1 day ago
LivaNova names former J&J MedTech exec as chief innovation officer
MassDevice
LivaNova today announced it appointed Ahmet Tezel to its newly created role of chief innovation officer, effective May 13, 2024.
2 weeks ago
LivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer
Business Wire
LivaNova PLC announced that Ahmet Tezel, Ph.D., will join the Company as Chief Innovation Officer, effective May 13, 2024.
2 weeks ago
LivaNova gives notice of personal patient data compromised by hackers
Medical Device Network
LivaNova has warned that patient contact details as well as care records could have been accessed by the malicious cyber-attack.
2 weeks ago
LivaNova Begins Sending Data Breach Letters Following October 2023 Data Breach
JD Supra
On December 13, 2023, LivaNova PLC filed a notice with the Securities and Exchange Commission disclosing a cybersecurity incident that...
2 weeks ago
LivaNova Earnings: Competitor's Oxygenator Woes Fuel Strong Revenue Growth
Morningstar
LivaNova Earnings: Competitor's Oxygenator Woes Fuel Strong Revenue Growth ... Narrow-moat LivaNova LIVN reported robust third-quarter results...
6 months ago
LivaNova PLC (LIVN) Surpasses Analyst Revenue Forecasts in Q1 2024
Yahoo Finance
Revenue: Reported $294.9 million, a 12.0% increase year-over-year, exceeding estimates of $278.66 million.
2 weeks ago
LivaNova Concludes Enrollment in OSA Neurostimulator Trial
Sleep Review
The trial will evaluate the aura6000 System for the reduction of AHI in adults with sleep apnea who have failed or are unwilling to use...
1 week ago